HCMNX
Price
$22.76
Change
-$0.20 (-0.87%)
Updated
Dec 17 closing price
RWIBX
Price
$64.43
Change
-$4.56 (-6.61%)
Updated
Dec 17 closing price
Ad is loading...

HCMNX vs RWIBX

Header iconHCMNX vs RWIBX Comparison
Open Charts HCMNX vs RWIBXBanner chart's image
HCM Dividend Sector Plus A
Price$22.76
Change-$0.20 (-0.87%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$64.43
Change-$4.56 (-6.61%)
VolumeN/A
CapitalizationN/A
HCMNX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HCMNX vs. RWIBX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMNX is a Hold and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 130B vs. HCMNX (1.79B). RWIBX pays higher dividends than HCMNX: RWIBX (1.05) vs HCMNX (0.12). HCMNX was incepted earlier than RWIBX: HCMNX (10 years) vs RWIBX (23 years). HCMNX is a more actively managed with annual turnover of: 178.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than HCMNX: RWIBX (250) vs HCMNX (2500). HCMNX annual gain was more profitable for investors over the last year : 24.75 vs. RWIBX (11.34). HCMNX return over 5 years is better than : 86.80 vs. RWIBX (29.64).
HCMNXRWIBXHCMNX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD29.7619.781304%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B130B1%
Annual Yield % from dividends0.121.0512%
Returns for 1 year24.7511.34218%
Returns for 3 years9.008.41107%
Returns for 5 years86.8029.64293%
Returns for 10 yearsN/A44.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics